Review of eprodisate for the treatment of renal disease in AA amyloidosis.
about
Heparin binding confers prion stability and impairs its aggregation.AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils.Targeting heparin and heparan sulfate protein interactions.Peptide Conjugates of Benzene Carboxylic Acids as Agonists and Antagonists of Amylin Aggregation.Learning from Synthetic Models of Extracellular Matrix; Differential Binding of Wild Type and Amyloidogenic Human Apolipoprotein A-I to Hydrogels Formed from Molecules Having Charges Similar to Those Found in Natural GAGs.
P2860
Review of eprodisate for the treatment of renal disease in AA amyloidosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Review of eprodisate for the treatment of renal disease in AA amyloidosis.
@en
Review of eprodisate for the treatment of renal disease in AA amyloidosis.
@nl
type
label
Review of eprodisate for the treatment of renal disease in AA amyloidosis.
@en
Review of eprodisate for the treatment of renal disease in AA amyloidosis.
@nl
prefLabel
Review of eprodisate for the treatment of renal disease in AA amyloidosis.
@en
Review of eprodisate for the treatment of renal disease in AA amyloidosis.
@nl
P2093
P2860
P356
P1476
Review of eprodisate for the treatment of renal disease in AA amyloidosis.
@en
P2093
Adam Rumjon
Muhammad M Javaid
Thomas Coats
P2860
P356
10.2147/IJNRD.S19165
P407
P577
2012-02-24T00:00:00Z